An evolving perception of the risk of rhBMP-2 use for anterior spinal interbody fusions

Spine J. 2011 Jun;11(6):520-1. doi: 10.1016/j.spinee.2011.04.019. Epub 2011 May 25.

Authors

Tomislav Smoljanovic¹, Ivan Bojanic

Affiliation

¹ Department of Orthopaedic Surgery, University Hospital Center Zagreb, School of Medicine, University of Zagreb, Salata 7, 10000 Zagreb, Croatia. [email protected]

PMID: 21612986
DOI: 10.1016/j.spinee.2011.04.019

No abstract available

Publication types

Comment

MeSH terms

Bone Morphogenetic Protein 2 / adverse effects*
Humans
Male
Postoperative Complications / chemically induced*
Recombinant Proteins / adverse effects
Sexual Dysfunction, Physiological / chemically induced*
Spinal Fusion / adverse effects*
Spinal Fusion / methods*
Transforming Growth Factor beta / adverse effects*

Substances

Bone Morphogenetic Protein 2
Recombinant Proteins
Transforming Growth Factor beta
recombinant human bone morphogenetic protein-2